Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Next generation sequencing and its application in deciphering head and neck cancer.

Jessri M, Farah CS.

Oral Oncol. 2014 Apr;50(4):247-53. doi: 10.1016/j.oraloncology.2013.12.017. Epub 2014 Jan 15.

PMID:
24440145
[PubMed - in process]
2.

Harnessing massively parallel sequencing in personalized head and neck oncology.

Jessri M, Farah CS.

J Dent Res. 2014 May;93(5):437-44. doi: 10.1177/0022034514524783. Epub 2014 Feb 20. Review.

PMID:
24557572
[PubMed - indexed for MEDLINE]
3.

Use of next generation sequencing in head and neck squamous cell carcinomas: A review.

Tabatabaeifar S, Kruse TA, Thomassen M, Larsen MJ, Sørensen JA.

Oral Oncol. 2014 Sep 12. pii: S1368-8375(14)00247-4. doi: 10.1016/j.oraloncology.2014.08.013. [Epub ahead of print] Review.

PMID:
25223596
[PubMed - as supplied by publisher]
4.

Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R; Head and Neck Cancer Disease Site Group.

Curr Oncol. 2010 Jun;17(3):37-48.

PMID:
20567625
[PubMed]
Free PMC Article
5.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
6.

Defining the genomic landscape of head and neck cancers through next-generation sequencing.

Rizzo G, Black M, Mymryk J, Barrett J, Nichols A.

Oral Dis. 2014 Apr 12. doi: 10.1111/odi.12246. [Epub ahead of print]

PMID:
24725020
[PubMed - as supplied by publisher]
7.

Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.

[No authors listed]

Drugs R D. 2004;5(5):293-6.

PMID:
15357628
[PubMed - indexed for MEDLINE]
8.

Animal models to study the mutational landscape for oral cavity and oropharyngeal cancers.

Spiotto MT, Pytynia M, Liu GF, Ranck MC, Widau R.

J Oral Maxillofac Res. 2013 Apr 1;4(1):e1. doi: 10.5037/jomr.2013.4101. Review.

PMID:
24422024
[PubMed]
Free PMC Article
9.

Next generation sequencing technology: Advances and applications.

Buermans HP, den Dunnen JT.

Biochim Biophys Acta. 2014 Oct;1842(10):1932-1941. doi: 10.1016/j.bbadis.2014.06.015. Epub 2014 Jul 1. Review.

PMID:
24995601
[PubMed - as supplied by publisher]
10.

Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.

Pant S, Weiner R, Marton MJ.

Front Oncol. 2014 Apr 17;4:78. doi: 10.3389/fonc.2014.00078. eCollection 2014. Review.

PMID:
24860780
[PubMed]
Free PMC Article
11.

Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?

Olthof NC, Straetmans JM, Snoeck R, Ramaekers FC, Kremer B, Speel EJ.

Rev Med Virol. 2012 Mar;22(2):88-105. doi: 10.1002/rmv.714. Epub 2011 Oct 7. Review.

PMID:
21984561
[PubMed - indexed for MEDLINE]
12.

Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.

Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP.

J Natl Cancer Inst. 2004 Mar 17;96(6):449-55.

PMID:
15026470
[PubMed - indexed for MEDLINE]
Free Article
13.

Clinical application of amplicon-based next-generation sequencing in cancer.

Chang F, Li MM.

Cancer Genet. 2013 Dec;206(12):413-9. doi: 10.1016/j.cancergen.2013.10.003. Epub 2013 Oct 11. Review.

PMID:
24332266
[PubMed - indexed for MEDLINE]
14.

Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics.

Gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich MJ.

J Pathol Inform. 2012;3:40. doi: 10.4103/2153-3539.103013. Epub 2012 Oct 31.

PMID:
23248761
[PubMed]
Free PMC Article
15.

Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.

Jain KS, Sikora AG, Baxi SS, Morris LG.

Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.

PMID:
23423883
[PubMed - indexed for MEDLINE]
16.

MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.

Mroz EA, Rocco JW.

Oral Oncol. 2013 Mar;49(3):211-5. doi: 10.1016/j.oraloncology.2012.09.007. Epub 2012 Oct 15.

PMID:
23079694
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Next-generation sequencing in the clinic: promises and challenges.

Xuan J, Yu Y, Qing T, Guo L, Shi L.

Cancer Lett. 2013 Nov 1;340(2):284-95. doi: 10.1016/j.canlet.2012.11.025. Epub 2012 Nov 19. Review.

PMID:
23174106
[PubMed - indexed for MEDLINE]
18.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Epub 2007 May 4. Review.

PMID:
17482300
[PubMed - indexed for MEDLINE]
19.

Next-generation sequencing: application in liver cancer-past, present and future?

Marquardt JU, Andersen JB.

Biology (Basel). 2012 Aug 31;1(2):383-94. doi: 10.3390/biology1020383.

PMID:
23750322
[PubMed]
Free PMC Article
20.

[Head and neck squamous cell cancer].

Tryggvason G, Sveinsson TE, Hjartarson H, Hálfdanarson TR.

Laeknabladid. 2009 Oct;95(10):671-80. Icelandic.

PMID:
19858546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk